[Federal Register Volume 85, Number 117 (Wednesday, June 17, 2020)]
[Notices]
[Pages 36605-36606]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-12977]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Meeting
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the National Cancer
Institute Council of Research Advocates.
The meeting will be held as a virtual meeting and is open to the
public. Individuals who plan to view the virtual meeting and need
special assistance or other reasonable accommodations to view the
meeting, should notify the Contact Person listed below in advance of
the meeting. The open session will be videocast and can be accessed
from the NIH Videocasting and Podcasting website (http://videocast.nih.gov).
Name of Committee: National Cancer Institute Council of Research
Advocates.
Date: July 16, 2020.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: Welcome and Chairwoman's Remarks, Legislative Update,
and Director's Update.
Place: National Institutes of Health, 9000 Rockville Pike,
Building 31, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Amy Williams, NCI Office of Advocacy Relations,
National Cancer Institute, NIH, 31 Center Drive, Building 31, Room
10A28, MSC 2580, Bethesda, MD 20892, 240-781-3360,
[email protected].
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
Information is also available on the Institute's/Center's home
page: NCRA: http://deainfo.nci.nih.gov/advisory/ncra/ncra.htm, where
an agenda and any additional information for the meeting will be
posted when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
[[Page 36606]]
Dated: June 11, 2020.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2020-12977 Filed 6-16-20; 8:45 am]
BILLING CODE 4140-01-P